Piper Jaffray Reiterates Neutral and PT of $78 on Gen-Probe

by Emily Austin, Benzinga Staff Writer
July 13, 2011 7:24 AM | 14 seconds read |
Piper Jaffray reiterated its Neutral rating on Gen-Probe GPRO. At the same time, Piper Jaffray left its price target on the company's stock unchanged at $78. On Tuesday, GPRO lost 0.67% of its value to finish the day at $65.52.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: ReiterationAnalyst RatingsHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!